González San Segundo Carmen, Calvo Manuel Felipe A, Santos Miranda Juan Antonio
Departamento de Oncología, Hospital General Universitario Gregorio Marañón, 28007 Madrid, España.
Clin Transl Oncol. 2005 Mar;7(2):47-54. doi: 10.1007/BF02710009.
Prescribed total radiation dose should be administered within in a specific time-frame and delays in commencing treatment and/or unplanned interruptions in radiation delivery are unacceptable because, in certain cancer sites, treatment-time prolongation can have a deleterious effect on local tumour control, and on patient outcomes. The present review evaluated the causes of initial treatment delays as well as interruptions in the scheduled radiotherapy. The literature search highlighted a significant concern in avoiding treatment-time prolongation in head and neck, cervix, breast and lung cancer. Among the causes involved in delay in radiotherapy commencement factors such as waiting lists, lack of material and human resources, and an increase complexity in planning, simulation and verification are highlighted. Most authors recommend radiotherapy commencement as soon as possible in radical (exclusive irradiation with active tumour present) and palliative situations with a maximum delay of no more than 6 to 8 weeks in the case of adjuvant radiotherapy (post-resection) programs. Interruptions during the course of treatment include: planned unit maintenance and servicing, acute patient toxicity or unexpected malfunction of linear accelerators; this last feature has the most deleterious effect on patients as well as radiotherapy practitioners. Interruptions that impact on the programmed time-course for radiotherapy needs to be compensated-for so as assure the biological equivalence in treatment efficacy with respect to cancer site and stage.
规定的总辐射剂量应在特定时间范围内给予,开始治疗的延迟和/或放射治疗过程中的意外中断是不可接受的,因为在某些癌症部位,治疗时间的延长可能会对局部肿瘤控制和患者预后产生有害影响。本综述评估了初始治疗延迟以及计划放射治疗中断的原因。文献检索突出了在避免头颈部、子宫颈、乳腺和肺癌治疗时间延长方面的重大问题。在放疗开始延迟的原因中,突出了诸如等待名单、缺乏物质和人力资源以及计划、模拟和验证的复杂性增加等因素。大多数作者建议在根治性(存在活性肿瘤的单纯照射)和姑息性情况下尽快开始放疗,在辅助放疗(切除后)方案中,最大延迟不超过6至8周。治疗过程中的中断包括:计划中的设备维护和保养、患者急性毒性反应或直线加速器意外故障;最后一个因素对患者和放疗从业者的影响最为有害。影响放疗计划时间进程的中断需要得到补偿,以确保在癌症部位和分期方面治疗效果的生物学等效性。